122 related articles for article (PubMed ID: 38809542)
21. Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.
Gardiner A; Kidd J; Elias MC; Young K; Mabey B; Taherian N; Cummings S; Malafa M; Rosenthal E; Permuth JB
J Natl Cancer Inst; 2022 Jul; 114(7):996-1002. PubMed ID: 35445726
[TBL] [Abstract][Full Text] [Related]
22. The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I; Schechter M; Dancour A; Lieberman S; Levi Z; Goldberg Y; Kedar I; Hasnis E; Half E; Levi GR; Katz L; Vainer ED; Genzel D; Aharoni M; Chen-Shtoyerman R; Abu-Freha N; Raitses-Gurevich M; Golan T; Bernstein-Molho R; Ben Yehoyada M; Gluck N; Rosner G
Cancer; 2024 Jan; 130(2):256-266. PubMed ID: 37861363
[TBL] [Abstract][Full Text] [Related]
23. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.
Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
[TBL] [Abstract][Full Text] [Related]
24. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic Cancer Surveillance in Carriers of a Germline
Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan.
Kitamura H; Morizane C; Tanabe N; Go I; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Ueno H; Yoshida T; Okusaka T
Pancreatology; 2023 Dec; 23(8):964-969. PubMed ID: 37914629
[TBL] [Abstract][Full Text] [Related]
28. Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Al Saati A; Vande Perre P; Plenecassagnes J; Gilhodes J; Monselet N; Cabarrou B; Lignon N; Filleron T; Telly D; Perello-Lestrade E; Feillel V; Staub A; Martinez M; Chipoulet E; Collet G; Thomas F; Gladieff L; Toulas C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762649
[TBL] [Abstract][Full Text] [Related]
29. Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma.
Zheng-Lin B; Rainone M; Varghese AM; Yu KH; Park W; Berger M; Mehine M; Chou J; Capanu M; Mandelker D; Stadler ZK; Birsoy O; Jairam S; Yang C; Li Y; Wong D; Benhamida JK; Ladanyi M; Zhang L; O'Reilly EM
Mol Diagn Ther; 2022 Nov; 26(6):645-653. PubMed ID: 36178671
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis.
Dal Buono A; Poliani L; Greco L; Bianchi P; Barile M; Giatti V; Bonifacio C; Carrara S; Malesci A; Laghi L
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980738
[TBL] [Abstract][Full Text] [Related]
31. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing.
Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W
Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154
[TBL] [Abstract][Full Text] [Related]
32. Results from London Regional Clinical Genetics services over a 5-year period on germline
Garrett A; Talukdar S; Izatt L; Brady AF; Whyte S; Josephs KS; Shanmugasundaram M; Guillemot LS; Vakili D; Ey S; Ahmed M
J Med Genet; 2022 Jun; 59(6):554-558. PubMed ID: 34266904
[TBL] [Abstract][Full Text] [Related]
33. Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients.
Nizic-Kos T; Krajc M; Blatnik A; Stegel V; Skerl P; Novakovic S; Gazic B; Besic N
Ann Surg Oncol; 2021 May; 28(5):2561-2570. PubMed ID: 33030641
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
[TBL] [Abstract][Full Text] [Related]
35. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
Lee K; Yoo C; Kim KP; Park KJ; Chang HM; Kim TW; Lee JL; Lee W; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Shin SH; Hwang DW; Song KB; Lee JH; Kim SC; Ryoo BY
Invest New Drugs; 2018 Feb; 36(1):163-169. PubMed ID: 28782087
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.
Peters MLB; Eckel A; Lietz A; Seguin C; Mueller P; Hur C; Pandharipande PV
Pancreatology; 2022 Sep; 22(6):760-769. PubMed ID: 35752568
[TBL] [Abstract][Full Text] [Related]
37. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.
Fountzilas E; Eliades A; Koliou GA; Achilleos A; Loizides C; Tsangaras K; Pectasides D; Sgouros J; Papakostas P; Rallis G; Psyrri A; Papadimitriou C; Oikonomopoulos G; Ferentinos K; Koumarianou A; Zarkavelis G; Dervenis C; Aravantinos G; Bafaloukos D; Kosmidis P; Papaxoinis G; Theochari M; Varthalitis I; Kentepozidis N; Rigakos G; Saridaki Z; Nikolaidi A; Christopoulou A; Fostira F; Samantas E; Kypri E; Ioannides M; Koumbaris G; Fountzilas G; Patsalis PC
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33429865
[TBL] [Abstract][Full Text] [Related]
40. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
